Jabra Enhance Select 200 vs Nuheara IQBuds Max
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

Jabra Enhance Select 200
The Jabra Enhance Select 200 is a premium-priced OTC hearing aid that earned a B grade with a SoundScore of 3.9/5 in our lab testing, placing it in the top 35% of the OTC hearing aid category. At $1,695, this behind-the-ear device offers solid performance in several key areas, though it faces stiff competition from higher-scoring alternatives at similar price points. In our testing, this device showed particular strength in speech clarity during quiet listening situations, scoring 3.5/5—0.67 points above the category average. Own-voice comfort was another highlight at 3.4/5, finishing 0.89 points above average, which suggests users may find their own voice sounds more natural compared to many competitors. Music streaming scored 2.6/5, which is above the category average by 0.68 points but still only mixed in absolute terms. The device's limitations become apparent in challenging listening environments. Speech in noise scored just 1.4/5, slightly below the category average and low in absolute terms—a consideration for users who frequently encounter noisy restaurants or social gatherings. Feedback handling scored 4.0/5, which is strong in absolute terms though 0.54 points below the category average. The Enhance Select 200 has earned Expert's Choice Awards in both 2023 and 2024, reflecting its reliable real-world performance. With Bluetooth streaming for both iPhone and Android, rechargeable batteries, and hands-free capability, it offers modern convenience features. However, shoppers should note that several competitors in this price range—including the Lucid Tala and Audicus Omni 2—scored notably higher in our testing. This device is best suited for users who prioritize speech clarity in quieter environments and own-voice comfort over performance in noisy situations.

Nuheara IQBuds Max
The Nuheara IQBuds Max is a budget-priced OTC hearing aid that earns a B grade with a SoundScore of 3.3/5 in our lab testing. Priced at $499, this visible-in-ear device from 2021 ranks #46 of 65 OTC hearing aids tested, placing it in the top 69% of its category. The standout feature of the IQBuds Max is its exceptional music streaming performance, scoring 4.3/5—a strong result that sits 2.38 points above the category average. For users who prioritize audio entertainment alongside hearing assistance, this device delivers notably better streaming fidelity than most OTC alternatives. However, speech performance presents a mixed picture. Speech in quiet scores 2.0/5, falling 0.78 points below the category average. Speech in noise is essentially at par with competitors at 1.5/5, which is above average for the category but low in absolute terms. Own voice comfort also trails the category average by 0.31 points with a score of 2.2/5. Feedback handling scores a solid 3.4/5 in absolute terms, though this falls 1.14 points below the category average. The IQBuds Max is best suited for users who value music and audio streaming quality over speech clarity, particularly those seeking an affordable entry point into amplification. Competing devices in this price range—including the Elehear Beyond (4.34/5) and Apple AirPods Pro 2 (4.04/5)—offer stronger overall sound performance for similar investment.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit